Altered expression of preproenkephalin and prodynorphin mRNA in a genetic model of paroxysmal dystonia

Brain Research

Volumn 1015, Issue 1-2, 2004, Pages 87-95

  Nobrega, J N ^a   Parkes, J H ^a   Wong, P ^a   Raymond, R ^a   Richter, A ^b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Basal ganglia; Choreoathetosis; Control of posture and sensory system; Dyskinesia; Motor systems and sensorimotor integration; Movement disorder; Neuropeptide

Indexed keywords

MESSENGER RNA; PREPROENKEPHALIN; PRODYNORPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DYSTONIA; GENETIC MODEL; HAMSTER; IMMUNOHISTOCHEMISTRY; NONHUMAN; PAROXYSMAL DYSTONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STRESS; TISSUE DISTRIBUTION;

ANALYSIS OF VARIANCE; ANIMALS; BASAL GANGLIA; BRAIN; CHOREATIC DISORDERS; CRICETINAE; DISEASE MODELS, ANIMAL; DYSTONIA; ENKEPHALINS; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; MUTATION; PROTEIN PRECURSORS; REFERENCE VALUES; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 3042513695     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.04.046     Document Type: Article

References (31)

1. Bennay M., Gernert M., Richter A. Spontaneous remission of paroxysmal dystonia coincides with normalization of entopeduncular activity in dtsz mutants. J. Neurosci. 21:2001;1-4. RC153
2. Bezard E., Ravenscroft P., Gross C.E., Crossman A.R., Brotchie J.M. Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine monkeys. Neurobiol. Dis. 8:2001;343-350
3. Bolam J.P., Hanley J.J., Booth P.A.C., Bevan M.D. Synaptic organization of the basal ganglia. J. Anat. 196:2000;527-542
4. Burgunder J.-M., Richter A., Löscher W. Expression of cholecystokinin, somatostatin, thyrotropin-releasing hormone, glutamic acid decarboxylase and tyrosine hydroxylase genes in the genetically dystonic hamster. Exp. Brain Res. 129:1999;114-120
5. Cenci M.A., Lee C.S., Björklund A. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA. Eur. J. Neurosci. 10:1998;2694-2706
6. Demirkiran M., Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann. Neurol. 38:1995;571-579
7. Di Chiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244:1998;1067-1080
8. sz) brains. Neuroscience. 112:2002;639-645
9. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:1992;133-139
10. Gerfen C.R., McGinty J.F., Young W.S. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neurosci. 11:1991;1016-1031
11. Gernert M., Richter A., Löscher W. Alterations in spontaneous single unit activity of striatal subdivisions during ontogenesis in mutant dystonic hamsters. Brain Res. 821:1999;277-285
12. Gernert M., Hamann M., Bennay M., Löscher W., Richter A. Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia. J. Neurosci. 20:2000;7052-7058
13. Hagelberg N., Kajander J.K., Nagren K., Hinkka S., Hietala J., Scheinin H. Mu-receptor agonism with alfentanil increases striatal dopamine D2 receptor binding in man. Synapse. 45:2002;25-30
14. Hamann M., Richter A. Striatal extracellular monoamine levels in a genetic animal model of primary paroxysmal dystonia. Mov. Disord. 17(suppl. 5):2002;S302. Neurol. Dis. 16 (2004) in press
15. Lavin A., Garcia-Munoz M. Electrophysiological changes in substantia nigra after dynorphin administration. Brain Res. 369:1986;298-302
16. Loughlin S.E., Leslie F.M., Fallon J.H. Endogenous opioid systems. Paxinos G. Rat Nervous System. 2nd ed. 1995;975-1001 Academic Press, San Diego
17. Morin L.P., Wood R.I. A Stereotaxic Atlas of the Golden Hamster Brain. 2001;Academic Press, San Diego
18. Morisette M., Grondin R., Goulet M., Bedard P.J., Di Paolo T. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists. J. Neurochem. 72:1999;682-692
19. 2 receptor binding in the genetically dystonic hamster. Neuroscience. 71:1996;927-936
20. 3H]WIN 35, 428 binding to the dopamine transporter in a hamster model of idiopathic paroxysmal dystonia. Neuroscience. 92:1999;211-217
21. Pickel V.M., Chan J., Sesack S.R. Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra. Brain Res. 602:1993;275-289
22. Rehders J.H., Löscher W., Richter A. Evidence for striatal dopaminergic overactivity in paroxysmal dystonia indicated by microinjections in a genetic rodent model. Neuroscience. 97:2000;267-277
23. Richter A., Löscher W. The kappa opioid receptor agonist U50, 488H exerts antidystonic activity in a mutant hamster model of generalized dystonia. Eur. J. Pharmacol. 236:1993;289-294
24. Richter A., Löscher W. Pathophysiology of idiopathic dystonia: findings from genetic animal models. Prog. Neurobiol. 54:1998;633-677
25. Richter A., Löscher W. Animal models of paroxysmal dystonia. Adv. Neurol. 89:2002;443-451
26. Schneider J.S., Decamp E., Wade T. Striatal preproenkephalin gene expression is upregulated in acute but not in chronic parkinsonian monkeys: implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology. J. Neurosci. 19:1999;6643-6649
27. Sinchak K., Eckersell C., Quezada V., Norell A., Micevych P. Preproenkephalin mRNA levels are regulated by acute stress and estrogen stimulation. Physiol. Behav. 69:2000;425-432
28. Steiner H., Gerfen C.R. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp. Brain Res. 123:1998;60-76
29. Todd R.D., Perlmutter J.S. Mutational and biochemical analysis of dopamine in dystonia. Mol. Neurobiol. 16:1998;135-147
30. Vitek J.L., Giroux M. Physiology of hypokinetic and hyperkinetic movement disorders: model for dyskinesia. Ann. Neurol. 47:2000;131-140
31. Westin J., Andersson M., Lundblad M. Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson's disease. Eur. J. Neurosci. 14:2001;1171-1176